Hatteras Venture Advisors IV SBIC SC 13D/A Clearside Biomedical / Hatteras Venture Advisors IV SBIC ownership change

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 7)*

CLEARSIDE BIOMEDICAL, INC.

(Name of Issuer)

Common Stock, $0.001 Par Value

(Title of Class of Securities)

185063104

(CUSIP Number)

Clay Thorp
280 S. Mangum Street,, Suite 350
Durham, NC, 27701
(919) 484-0730

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

09/13/2024

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No. 185063104

1

Name of reporting person

Hatteras Venture Advisors IV SBIC, LLC

2

Check the appropriate box if a member of a Group (See Instructions)

  (a)
  (b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13D

CUSIP No. 185063104

1

Name of reporting person

Hatteras Venture Partners IV SBIC, LP

2

Check the appropriate box if a member of a Group (See Instructions)

  (a)
  (b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13D

CUSIP No. 185063104

1

Name of reporting person

Hatteras Venture Advisors IV, LLC

2

Check the appropriate box if a member of a Group (See Instructions)

  (a)
  (b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13D

CUSIP No. 185063104

1

Name of reporting person

Hatteras Venture Partners IV, LP

2

Check the appropriate box if a member of a Group (See Instructions)

  (a)
  (b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13D

CUSIP No. 185063104

1

Name of reporting person

Hatteras NC Fund, LP

2

Check the appropriate box if a member of a Group (See Instructions)

  (a)
  (b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13D

CUSIP No. 185063104

1

Name of reporting person

John C. Crumpler

2

Check the appropriate box if a member of a Group (See Instructions)

  (a)
  (b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 125,793.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 125,793.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

125,793.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0.2 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

CUSIP No. 185063104

1

Name of reporting person

Robert A. Ingram

2

Check the appropriate box if a member of a Group (See Instructions)

  (a)
  (b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 130,881.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 130,881.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

130,881.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0.2 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

CUSIP No. 185063104

1

Name of reporting person

Kenneth B. Lee

2

Check the appropriate box if a member of a Group (See Instructions)

  (a)
  (b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 86,324.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 86,324.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

86,324.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0.1 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

CUSIP No. 185063104

1

Name of reporting person

Clay B. Thorp

2

Check the appropriate box if a member of a Group (See Instructions)

  (a)
  (b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 313,641.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 313,641.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

313,641.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0.4 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

Includes 152,500 shares of Common Stock subject to options held by Mr. Thorp that are exercisable within 60 days of February 21, 2025.

SCHEDULE 13D

CUSIP No. 185063104

1

Name of reporting person

Douglas Reed

2

Check the appropriate box if a member of a Group (See Instructions)

  (a)
  (b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 127,011.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 127,011.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

127,011.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0.2 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock, $0.001 Par Value
(b)	Name of Issuer: CLEARSIDE BIOMEDICAL, INC.
(c)	Address of Issuer's Principal Executive Offices: 900 NORTH POINT PARKWAY, SUITE 200, ALPHARETTA, GEORGIA , 30005.
Item 1 Comment: This Amendment No. 7 on Schedule 13D amends the statement on Schedule 13D, dated June 7, 2016, which relates to the Common Stock, par value $0.001 per share (the "Common Stock") of Clearside Biomedical, Inc. (the "Issuer") which was previously amended on Schedule 13D/A, dated January 20 and April 17, 2017, March 21, 2018, July 17 and December 4, 2019, and January 4, 2023 filed by: Hatteras Venture Advisors IV SBIC, LLC ("HVA SBIC") Hatteras Venture Partners IV SBIC, LP ("HVP SBIC") Hatteras Venture Advisors IV, LLC ("HVA IV") Hatteras Venture Partners IV, LP ("HVP IV") Hatteras NC Fund, LP ("Hatteras Fund") John C. Crumpler Robert A. Ingram Kenneth B. Lee Clay B. Thorp Douglas Reed (collectively, the "Reporting Persons"). Except as expressly amended below, the Schedule 13D, dated June 7, 2016, remains in effect.
Item 5.	Interest in Securities of the Issuer
(a)	HVA SBIC-- 0 or 0% HVP SBIC -- 0 or 0% HVA IV-- 0 or 0% HVP IV -- 0 or 0% Hatteras Fund-- 0 or 0% John C. Crumpler -- 125,793 or 0.2% Robert A. Ingram -- 130,881 or 0.2% Kenneth B. Lee -- 86,324 or 0.1% Clay B. Thorp -- 313,641 or 0.4% Douglas Reed -- 127, 011 or 0.2%
(b)	(i) Sole power to vote or to direct the vote HVA SBIC-- 0 HVP SBIC -- 0 HVA IV-- 0 HVP IV -- 0 Hatteras Fund-- 0 John C. Crumpler -- 125,793 Robert A. Ingram -- 130,881 Kenneth B. Lee -- 86,324 Clay B. Thorp -- 313,641 Douglas Reed -- 127, 011 (iii) Sole power to dispose or to direct the disposition of HVA SBIC-- 0 HVP SBIC -- 0 HVA IV-- 0 HVP IV -- 0 Hatteras Fund-- 0 John C. Crumpler -- 125,793 Robert A. Ingram -- 130,881 Kenneth B. Lee -- 86,324 Clay B. Thorp -- 313,641 Douglas Reed -- 127, 011 (iv) Shared power to dispose or to direct the disposition of HVA SBIC-- 0 HVP SBIC -- 0 HVA IV-- 0 HVP IV -- 0 Hatteras Fund-- 0 John C. Crumpler -- 0 Robert A. Ingram -- 0 Kenneth B. Lee -- 0 Clay B. Thorp -- 0 Douglas Reed -- 0 (ii) Shared power to vote or to direct the vote HVA SBIC-- 0 HVP SBIC -- 0 HVA IV-- 0 HVP IV -- 0 Hatteras Fund-- 0 John C. Crumpler -- 0 Robert A. Ingram -- 0 Kenneth B. Lee -- 0 Clay B. Thorp -- 0 Douglas Reed -- 0
(e)	September 13, 2024

SIGNATURE
	After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Hatteras Venture Advisors IV SBIC, LLC

Signature:	/s/ Clay B. Thorp
Name/Title:	Clay B. Thorp, Manager
Date:	02/21/2025

Hatteras Venture Partners IV SBIC, LP

Signature:	/s/ Clay B. Thorp
Name/Title:	Clay B. Thorp, Manager
Date:	02/21/2025

Hatteras Venture Advisors IV, LLC

Signature:	/s/ Clay B. Thorp
Name/Title:	Clay B. Thorp, Manager
Date:	02/21/2025

Hatteras Venture Partners IV, LP

Signature:	/s/ Clay B. Thorp
Name/Title:	Clay B. Thorp, Manager
Date:	02/21/2025

Hatteras NC Fund, LP

Signature:	/s/ Clay B. Thorp
Name/Title:	Clay B. Thorp, Manager
Date:	02/21/2025

John C. Crumpler

Signature:	/s/ Clay B. Thorp
Name/Title:	Clay B. Thorp, by Power of Attorney
Date:	02/21/2025

Robert A. Ingram

Signature:	/s/ Clay B. Thorp
Name/Title:	Clay B. Thorp, by Power of Attorney
Date:	02/21/2025

Kenneth B. Lee

Signature:	/s/ Clay B. Thorp
Name/Title:	Clay B. Thorp, by Power of Attorney
Date:	02/21/2025

Clay B. Thorp

Signature:	/s/ Clay B. Thorp
Name/Title:	Clay B. Thorp
Date:	02/21/2025

Douglas Reed

Signature:	/s/ Clay B. Thorp
Name/Title:	Clay B. Thorp, by Power of Attorney
Date:	02/21/2025

Comments accompanying signature:

This Amendment No. 7 to Schedule 13D was executed by Clay B. Thorp on behalf of the individuals listed above pursuant to a Power of Attorney a copy of which was previously filed with the Reporting Person's Schedule 13D filed with the SEC on June 17, 2016 and as amended on February 8 and April 25, 2017, March 21, 2018, July 17 and December 4, 2019 and January 4, 2023.